Evaluation of Cholangiocarcinomas (CCA) by Next Generation Sequencing (NGS) Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies
Publication
, Conference
Al-Rohil, R; Rand, JV; Jones, DM; Lee, HJ; Sheehan, CE; Otto, G; Palmer, G; Yelensky, R; Lipson, D; White, E; Balasubramanian, S; Garcia, L ...
Published in: MODERN PATHOLOGY
February 1, 2013
Duke Scholars
Published In
MODERN PATHOLOGY
ISSN
0893-3952
Publication Date
February 1, 2013
Volume
26
Start / End Page
397A / 397A
Location
Baltimore, MD
Publisher
NATURE PUBLISHING GROUP
Conference Name
102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP)
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Al-Rohil, R., Rand, J. V., Jones, D. M., Lee, H. J., Sheehan, C. E., Otto, G., … Ross, J. S. (2013). Evaluation of Cholangiocarcinomas (CCA) by Next Generation Sequencing (NGS) Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies. In MODERN PATHOLOGY (Vol. 26, pp. 397A-397A). Baltimore, MD: NATURE PUBLISHING GROUP.
Al-Rohil, R., J. V. Rand, D. M. Jones, H. J. Lee, C. E. Sheehan, G. Otto, G. Palmer, et al. “Evaluation of Cholangiocarcinomas (CCA) by Next Generation Sequencing (NGS) Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies.” In MODERN PATHOLOGY, 26:397A-397A. NATURE PUBLISHING GROUP, 2013.
Al-Rohil R, Rand JV, Jones DM, Lee HJ, Sheehan CE, Otto G, et al. Evaluation of Cholangiocarcinomas (CCA) by Next Generation Sequencing (NGS) Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies. In: MODERN PATHOLOGY. NATURE PUBLISHING GROUP; 2013. p. 397A-397A.
Al-Rohil, R., et al. “Evaluation of Cholangiocarcinomas (CCA) by Next Generation Sequencing (NGS) Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies.” MODERN PATHOLOGY, vol. 26, NATURE PUBLISHING GROUP, 2013, pp. 397A-397A.
Al-Rohil R, Rand JV, Jones DM, Lee HJ, Sheehan CE, Otto G, Palmer G, Yelensky R, Lipson D, White E, Balasubramanian S, Garcia L, Mahoney K, Richards T, Terzic S, Banning V, Curran J, Downing S, Miller V, Stephens P, Ross JS. Evaluation of Cholangiocarcinomas (CCA) by Next Generation Sequencing (NGS) Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies. MODERN PATHOLOGY. NATURE PUBLISHING GROUP; 2013. p. 397A-397A.
Published In
MODERN PATHOLOGY
ISSN
0893-3952
Publication Date
February 1, 2013
Volume
26
Start / End Page
397A / 397A
Location
Baltimore, MD
Publisher
NATURE PUBLISHING GROUP
Conference Name
102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP)
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 11 Medical and Health Sciences